Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | IL-5 | 10.0 | 57 | ||||
RA2159 | 2 | IL-5 | 10.0 | 57 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | IL-5 | 9.0 | 64 | ||||
N2645 | 2 | IL-5 | 9.0 | 50 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | IL-5 | 11.5 | 56 | ||||
RA2708 | 2 | IL-5 | 11.0 | 56 | |||||||
0 | IL-5 | 9.0 | 43 | ||||||||
0 | IL-5 | 11.5 | 46 | ||||||||
0 | IL-5 | 10.0 | 46 | ||||||||
0 | IL-5 | 10.0 | 60 | ||||||||
0 | IL-5 | 12.0 | 56 | ||||||||
0 | IL-5 | 11.0 | 49 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-5 | 10.0 | 70 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | IL-5 | 10.5 | 64 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-5 | 10.0 | 80 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | IL-5 | 9.0 | 72 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-5 | 10.0 | 80 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | IL-5 | 11.0 | 68 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-5 | 10.0 | 75 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-5 | 10.0 | 54 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | IL-5 | 10.0 | 53 | ||||
RA1869 | 3 | IL-5 | 10.0 | 71 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | IL-5 | 11.0 | 76 | ||||
N2759 | 3 | IL-5 | 8.0 | 60 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | IL-5 | 12.0 | 69 |